The National Institutes of Health today named five new directors to its advisory committee. They are David Botstein, Nancy Adler, Alexander Lerner, Christine Seidman, and Tadataka Yamada.
Botstein is the director of Lewis-Sigler Institute of Integrative Genomics at Princeton. He has developed novel methods to study budding yeast and the functions of the actin and tubulin cytoskeletons. He has made theoretical contributions to the human genome linkage mapping. His current research focuses on yeast biology at the system level.
Adler is a professor of psychology at UC San Francisco. She's a member of the Institute of Medicine of the National Academy of Sciences.
Lerner is CEO of the Illinois State Medical Society. He was formerly president of his own consulting firm.
Seidman is a professor in the departments of medicine and genetics at Harvard Medical School and Brigham and Women's Hospital. She is also an investigator at the Howard Hughes Medical Institute.
Yamada is a director and chairman of research and development at GlaxoSmithKline. He was formerly chairman of the department of internal medicine at the University of Michigan Medical School.
The National Institute of Allergy and Infectious Diseases today named four new members to its principal advisory board. They are Barbara Baird, Kathryn Edwards, Martin Rosenberg, and Megan Sykes.
Baird is director of the nanotechnology center at Cornell University and principal investigator for Cornell's training grant in molecular biophysics.
Edwards is professor of pediatrics at Vanderbilt University and leads the NIAID-supported vaccine and treatment evaluation unit at Vanderbilt. She has served as an advisor to the Centers for Disease Control and Prevention and the Food and Drug Administration.
Rosenberg is chief scientific officer of Promega. He is a director at Promega, Cubist Pharmaceuticals, Medical College of Wisconsin Research Foundation, Nereus Pharmaceuticals, Anacor Pharmaceuticals, and Scarab Genomics.
Sykes is a professor of medicine at Harvard Medical School. She is an immunologist and associate director of the Transplantation Biology Research Center at Massachusetts General Hospital.
Donald Kaplan has retired as president and chief operating officer of Protein Polymer Technologies "to pursue other opportunities," the company said yesterday. Kaplan will continue to serve as a director and consultant.
Affymetrix said today it had named Robert Trice to its board of directors.
Trice is senior vice president for business development at Lockheed Martin and chairman and CEO of Lockheed Martin Global. Prior to that, he was vice president and general manager for business development at McDonnell Douglas Aerospace.
Applied Biosystems appointed Mark Bloomfield vice president sales molecular biology Europe as of Nov. 1, 2005, the company announced yesterday.
Bloomfield previously held executive positions at the European divisions of Thermo Electron, Agilent, and Hewlett-Packard.
John Hatsopoulos joined Viaspace as a director, the defense technology company said today.
Hatsopoulos is CEO of American Distributed Generation and chairman of GlenRose Capital, a leveraged buyout investment fund. Previously, he was co-founder, vice chairman, president and chief financial officer of Thermo Electron.